Healios K.K. (OTCMKTS:HLOSF) Short Interest Update

Healios K.K. (OTCMKTS:HLOSF) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 50,500 shares, a growth of 4,490.9% from the September 30th total of 1,100 shares. Based on an average daily trading volume, of 200 shares, the short-interest ratio is presently 252.5 days.

Healios K.K. Price Performance

OTCMKTS HLOSF opened at 1.50 on Friday. Healios K.K. has a 52 week low of 0.93 and a 52 week high of 1.73. The stock has a fifty day moving average of 1.59 and a 200-day moving average of 1.26.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.